(NASDAQ:SLNO) LOS ANGELES--(BUSINESS WIRE)---- $SLNO--SLNO Investors Have Opportunity to Join Soleno Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Related Questions
How likely is a material settlement or judgment from the fraud investigation, and what magnitude could it have on SLNO's valuation?
What is the timeline for the investigation and potential legal actions, and how might that affect short‑term trading volatility?
Could this lawsuit trigger additional regulatory scrutiny or impact existing partnerships and pipeline milestones for Soleno Therapeutics?